top of page

Lewis Saul

​Principal 

Since Lewis J. Saul founded the firm in 1980, he has dedicated his career to representing injured individuals, protecting the rights of everyday people and fighting to sustain the health and safety of communities around the country. Mr. Saul has over 40 years of experience in consumer protection, product liability, and personal injury law,
concentrating in complex litigation involving prescription drugs, medical devices, defective products, and toxic substances. In guiding Lewis Saul & Associates, P.C., as a public interest law firm, he has also taken the lead and litigated cases involving consumer fraud, corporate wrongdoing, and discrimination.
 

 

Over his career, Mr. Saul has represented thousands of clients from around the world in United States courts, investigating, developing, litigating and successfully resolving some of the biggest mass tort and toxic tort cases in United States history. Mr. Saul’s experience and tenacious representation of his clients has led to favorable outcomes against even the largest of corporate opponents.
 

 

 

Over the last 44 years, Mr. Saul has successfully represented clients injured by pharmaceutical drugs, including:

 

  • Avelox​

  • Baycol

  • Diethylstilbestrol (DES)

  • Depakote

  • Ephedra

  • Fen Phen

  • Gadolinium

  • Levaquin

  • OxyContin

  • Phenylpropanolamine (PPA)

  • Rezulin

  • Stadol

  • Trovan

  • Vioxx

  • Yaz/Yasmin/Ocella

  • Zithromax

  • Zyprexa
     

​

Mr. Saul has also successfully represented clients injured by medical devices, including:
 

  • Defective hip implants

  • Dalkon Shield

  • Transvaginal and hernia mesh

  • Copper 7 IUDs

  • Silicone gel breast implants

  • Numerous heart valve and cardiac pacemakers

  • Penile and testicular implants

  • Norplant

  • NuvaRing

  • Ortho Evra

 

Mr. Saul’s experience and professional approach has resulted in his appointment to leadership positions in complex litigations around the country, involving matters from consumer protection and environmental issues to medical devices and pharmaceutical products.

 


 

Litigation Leadership Experience

 

​​

  • LaRocque v. TRS Recovery Services, Inc., 285 F.R.D. 139 (D. Maine 2012): Co-

Lead Counsel and counsel for plaintiff in a class action case involving violations
of the Fair Credit Reporting Act for a deceptive collection letter for returned
checks and other fees.

 

​​

  • In re Levaquin Products Liability Litigation, MDL No. 1943 (2008): Co-Lead

Counsel and MDL Liaison Counsel litigating claims against Johnson & Johnson
and Ortho-McNeil Pharmaceutical, Inc. on behalf of hundreds of individuals who
have sustained injuries from the fluoroquinolone antibiotic, Levaquin.

 

​​

  • In re Hannaford Customer Data Security Breach Litigation, MDL No. 1954

(2008): Co-Lead Counsel representing individuals whose confidential financial
and personal information was stolen during credit card and debit card
transactions at Hannaford and Sweetbay supermarkets in Maine, New
Hampshire, Vermont, Massachusetts, New York and Florida during late 2007 and
early 2008 as a result of the failure of Hannaford to maintain the security of its
electronic payment system.

 

​​

  • H. Louis Farmer, Jr., et al. v. TD Banknorth, Inc. et al., CV-07-39 (Maine Sup. Ct.

2007) and In re TD Banknorth Shareholders Litigation, C.A. No. 2557-VCL
(Delaware Ct. of Chancery 2007): Co-Counsel for Plaintiff Farmer and the Class
in shareholder derivative class action filed in Maine against TD Banknorth, TD
Bank Financial Group, and their directors for breach of their fiduciary duties to
shareholders in acquisition of all outstanding shares of TD Banknorth common
stock by TD Bank Financial Group. The Farmer case was transferred to
Delaware for consolidation with several related class actions. The firm is Co-
Class Counsel in the Delaware action.

 

​​

  • In re The Delaco Company, Civ. Action No. 04-10899 (S.D.N.Y. Bankruptcy Ct.

2004): Served as co-counsel with a New York bankruptcy firm representing the
rights of a group of Dexatrim diet drug users in Chapter 11 bankruptcy
proceedings in the United States District Court for the Southern District of New
York. Extensive negotiations with Debtor’s counsel and the Tort Claimants

 

Committee resulted in fairer compensation and administration of Dexatrim claims against The Delaco Company under the Debtor’s Reorganization Plan. 

 

​​

  • Millett et al. v. Atlantic Richfield Co., et al., CV-98-555 (Maine Sup. Ct. 2000) and

In re MTBE Products Liability Litigation, MDL No. 1358, OO CIV. 1898 (S.D.N.Y.
2002): Served as Lead Counsel in a class action suit filed in Maine Superior
Court against Atlantic Richfield Company and other oil and chemical companies
for groundwater contamination due to methyl tertiary butyl ether (MTBE) – a
gasoline additive. Millett was the first MTBE contamination class action filed in
the country. The firm later filed MTBE class actions in New York and
successfully sought consolidation by the Judicial Panel on Multidistrict Litigation
of all federal MTBE cases to the United States District Court for the Southern
District of New York in MDL-1358, In re Methyl Tertiary-Butyl Ether Products
Liability Litigation. Mr. Saul was appointed by the Honorable Shira Scheindlin as
Co-Lead Counsel in MDL 1358.

 

​​

  • Meyers et al. v. State of Texas, 00-cv-00430-SS (W.D. Tex. 2000): Served as

Co-Class Counsel on behalf of handicapped plaintiffs in a class action involving
violations of the Americans with Disabilities Act.

 

​​

  • Deminne v. Smart Corporation, Civ. Action No. 151794 (Sup. Ct. Montgomery

Cty. Md. 1998): Appointed Class Counsel in class action brought on behalf of
residents of Maryland who were overcharged for copies of their medical records.
The Maryland Attorney General joined in the suit. The case resulted in a
favorable class settlement for all class members.

 

​​

  • In re Silicon Gel Products Liability Litigation, MDL No. 926 (N.D. Ala. 1995):

Appointed as Co-Vice-Chairperson of the Foreign Claimants Subcommittee to
represent the interests of approximately 60,000 non-U.S. claimants injured by
defective silicone gel breast implants.

 

​​

  • Vorhis v. American Medical Systems, C-1-94-824 (S.D. Ohio 1994): Appointed

as Class Counsel for nationwide class of men implanted with defective penile
implants manufactured by AMS. When the case was later decertified, the firm
successfully fought defendant’s forum non conveniens motions and, together
with two other law firms, filed over 700 individual cases in Hennepin County,
Minnesota. The firm helped organize an informal “plaintiff steering committee” to
successfully coordinate and manage the massive statewide litigation. Soon after
the presiding judge selected bellwether cases for trial, AMS settled all 700 filed
claims.​

​

 

  • In re Copley Pharmaceutical, Inc., “Albuterol” Products Liability Litigation, MDL

No. 1013 (Wyo. 1994): Represented two lead plaintiffs and served as Member of
Plaintiff Steering Committee in the country’s first national personal injury class
action that went to trial. The case was favorably settled after a three month trial
just before closing arguments.

​​​

  • In re Domestic Air Transportation Antitrust Litigation, 148 F.R.D. 297 (N.D. Ga.

1993): The firm appeared as objecting counsel on behalf of foreign class
members who were not furnished notice of a proposed settlement.

​​

  • Bowling v. Pfizer, Inc., Case No. C-1-91-256 (S.D. Ohio 1991): Appointed by the

federal court as Special Counsel to Class Counsel to represent the interests of
non-U.S. claimants injured by defective Bjork-Shiley convexo-concave heart
valves in a worldwide class action settlement. The firm played an important role
in negotiating significant enhancements to the terms of the settlement beneficial
to foreign claimants.

 

​​

  • Creutzfeldt-Jakob Disease (CJD) Litigation: The firm represented several

families in the world’s first lawsuits involving the deadly Creutzfeld-Jacob disease
contracted from human growth hormone.


 

 

Bar Admissions

 

​​

  • District of Columbia, 1980

  • Virginia, 1980

  • New York, 2007

  • U.S. District Court District of Columbia, 1981

  • U.S. District Court Eastern District of Virginia, 1984

  • U.S. District Court District of Maryland, 1985

  • U.S. District Court Northern District of California, 1991

  • U.S. District Court Southern District of New York, 2007

  • U.S. District Court Eastern District of New York, 2020

  • U.S. District Court of Minnesota, 2008

  • U.S. Court of Appeals District of Columbia Circuit, 1980

  • U.S. Court of Appeals Federal Circuit, 1992

  • U.S. Court of Appeals 4th Circuit, 1984

  • U.S. Court of Appeals 6th Circuit, 1999

  • U.S. Court of Appeals 8th Circuit, 2011

  • U.S. Court of Appeals 9th Circuit, 2004

  • U.S. Court of Appeals 11th Circuit, 1993

  • U.S. Supreme Court, 1996


PROFESSIONAL MEMBERSHIPS

 

  • Member, American Bar Association

  • Past Chair, AAJ Levaquin Litigation Group

  • Past Chair, AAJ MTBE Litigation Group

  • Past Co-chair, AAJ Cardiac Device Litigation Group

  • Past Co-Chair, AAJ Quinolone Antibiotic Litigation Group

  • Member, State of New York Bar Association

  • Member, New York City Bar Association 

  • Member, District of Columbia Bar Association

EDUCATION

  • Doctor of Jurisprudence, George Mason School of Law, Arlington, VA, 1979

  • Bachelor of Arts, Goddard College, Plainfield, VT, Degree in Fine Arts, 1974

bottom of page